Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.6 USD | -0.81% | +9.73% | -11.26% |
04-26 | Belite Bio Unveils Plan to Offer 651,380 American Depository Shares | MT |
03-22 | Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan | MT |
Evolution of the average Target Price on Belite Bio, Inc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Belite Bio, Inc
Maxim | |
HC Wainwright | |
Cantor Fitzgerald | |
SVB Securities LLC | |
Benchmark Capital |
EPS Revisions
- Stock Market
- Equities
- BLTE Stock
- Consensus Belite Bio, Inc